Skip to main content

A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients (LANDI-PED).

Open
  • Protocol code: LDLL300.301
  • EudraCT code: 2015-001129-17
  • Service: Pediatric Cardiology
  • Principal investigator:  Rosés i Noguer, Ferran
  • Pathology: Malalties del sistema circulatori
  • Phase: Fase III
  • Status: Recruiting volunteers